The state of Missouri has promulgated regulations effective July 30, 2015 that formally authorize electronic prescribing of controlled substances in Missouri. With these new regulations, Missouri becomes the final state to allow electronic prescribing of controlled substances. Although the Drug Enforcement Administration implemented changes in 2010 to permit electronic prescribing of such drugs, some states, like many prescribers, have been slow to adopt the practice. As we reported in a blog post earlier this year, as of December 2013, approximately one-third of pharmacies were equipped to handle e-prescriptions of controlled substances, but only 1% of prescribers were able to e-prescribe controlled substances.

With all states now allowing e-prescribing of controlled substances, however, we may see faster growth in the number of providers and pharmacies capable of e-prescribing or accepting e-prescriptions of controlled substances. E-prescribing is viewed as a way to reduce the abuse of controlled substances, which continues to be an important public health issue. Regulations authorizing e-prescribing in all 50 states may also encourage the development of new and more accessible e-prescribing technologies for providers and pharmacies.

 

 

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Liza Khan Liza Khan

Liza Khan practices in the areas of federal-state programs and health care. Ms. Khan helps clients navigate state and federal rules and policies, including those governing the Medicare and Medicaid programs. Ms. Khan regularly counsels clients on the new mandates of the Affordable…

Liza Khan practices in the areas of federal-state programs and health care. Ms. Khan helps clients navigate state and federal rules and policies, including those governing the Medicare and Medicaid programs. Ms. Khan regularly counsels clients on the new mandates of the Affordable Care Act, Medicare and Medicaid price reporting issues, coverage and reimbursement of drugs and devices under federal health care programs, Medicaid Section 1115 demonstration waivers, among other issues.